HomeNewsGlobal Pharma

SSI Mantra Becomes India's First CDSCO Certified Robotic System for Telesurgery

SSI Mantra Becomes India's First CDSCO Certified Robotic System for Telesurgery

SS Innovations has achieved a major milestone by becoming the first and only company in India to receive Central Drugs Standard Control Organization (CDSCO) regulatory approval for Telesurgery and Teleproctoring, signifying a monumental leap in surgical robotics.

This landmark achievement positions SSI Mantra as the first surgical robotic system in India authorized to perform these advanced capabilities. It paves the way for SS Innovations' commitment to advancing surgical technology, making cutting-edge procedures more accessible, and reinforcing the position of India as a global leader in healthcare innovation.

By enabling Telesurgery and Teleproctoring, the system aims to decentralize and democratize access to surgical expertise, addressing critical gaps in healthcare, particularly in remote areas, where access to specialized medical care has often been a challenge.

Celebrating the remarkable achievement, SS Innovations Founder, Chairman, and CEO, Dr. Sudhir Srivastava, said, “Reaching this milestone with SSI Mantra is a testament to our vision of transforming surgical practices, enhancing access, and driving the adoption of robotic surgery. Telesurgery and Teleproctoring have been a dream in the making for over four decades, and today, it has finally come to life. With the technology and bandwidth available now, we can truly decentralize and democratize surgical expertise, reaching patients and surgeons in the most remote parts of India and the world. This innovation is a game-changer, especially for our country, where much of the population lives in smaller towns and rural areas. By enabling remote surgical intervention, we are reshaping the future of healthcare.”

This historic achievement marks a significant step forward in India’s healthcare landscape, with SSI leading the charge in revolutionizing surgical care through cutting-edge technology.

The approval of Telesurgery and Teleproctoring capabilities for SSI Mantra Surgical Robotic Systems not only underscores the company’s commitment to innovation but also opens up new possibilities for accessible, high-quality healthcare across India and beyond. 

More news about: global pharma | Published by Aishwarya | December - 10 - 2024

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members